Current and future pharmacologic treatment of sarcopenia.

[1]  S. Harris,et al.  Vitamin D and Its Role in Skeletal Muscle , 2009, Calcified Tissue International.

[2]  T. Trappe,et al.  Influence of acetaminophen and ibuprofen on skeletal muscle adaptations to resistance exercise in older adults. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

[3]  D. Reeds,et al.  Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial. , 2011, The American journal of clinical nutrition.

[4]  A. Molfino,et al.  Contribution of anorexia to tissue wasting in cachexia , 2010, Current opinion in supportive and palliative care.

[5]  G. B. Phillips.  Adverse events associated with testosterone administration. , 2010, The New England journal of medicine.

[6]  S. Anker,et al.  Advances in understanding and treating cardiac cachexia: highlights from the 5th Cachexia Conference. , 2010, International journal of cardiology.

[7]  R. Feinn,et al.  Dehydroepiandrosterone Combined with Exercise Improves Muscle Strength and Physical Function in Frail Older Women , 2010, Journal of the American Geriatrics Society.

[8]  A. Angelini,et al.  Skeletal muscle proteins oxidation in chronic right heart failure in rats: can different beta-blockers prevent it to the same degree? , 2010, International journal of cardiology.

[9]  M. Sheffield-Moore,et al.  Pharmacological Vasodilation Improves Insulin-Stimulated Muscle Protein Anabolism but Not Glucose Utilization in Older Adults , 2010, Diabetes.

[10]  L. Ferrucci,et al.  Nutritional recommendations for the management of sarcopenia. , 2010, Journal of the American Medical Directors Association.

[11]  E. Hoffman,et al.  A randomized clinical trial to assess the effect of statins on skeletal muscle function and performance: rationale and study design. , 2010, Preventive cardiology.

[12]  S. Anton,et al.  Beneficial Effects of a Q-ter® Based Nutritional Mixture on Functional Performance, Mitochondrial Function, and Oxidative Stress in Rats , 2010, PloS one.

[13]  J. Bain.  Testosterone and the aging male: to treat or not to treat? , 2010, Maturitas.

[14]  D. Marks,et al.  Genetic and pharmacologic blockade of central melanocortin signaling attenuates cardiac cachexia in rodent models of heart failure , 2010, The Journal of endocrinology.

[15]  A. Gómez-Foix,et al.  Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells. , 2010, Endocrinology.

[16]  M. Kohzuki,et al.  Effects of Estradiol, Angiotensin-Converting Enzyme Inhibitor and Exercise Training on Exercise Capacity and Skeletal Muscle in Old Female Rats , 2010, Clinical and experimental hypertension.

[17]  S. Anker,et al.  Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference , 2010, Expert opinion on investigational drugs.

[18]  S. Roberts,et al.  Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. , 2010, The Journal of clinical endocrinology and metabolism.

[19]  J. Wernerman,et al.  Effects of Growth Hormone and Insulin-Like Growth Factor-1 on Postoperative Muscle and Substrate Metabolism , 2009, Journal of nutrition and metabolism.

[20]  B. Hamilton,et al.  Vitamin D and Human Skeletal Muscle , 2009, Scandinavian journal of medicine & science in sports.

[21]  A. Meikle.  Testosterone and Growth Hormone Improve Body Composition and Muscle Performance in Older Men , 2010 .

[22]  M. Cesari,et al.  ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study. , 2010, Journal of the American Medical Directors Association.

[23]  B. Dawson-Hughes,et al.  Impact of supplementation with bicarbonate on lower-extremity muscle performance in older men and women , 2010, Osteoporosis International.

[24]  Y. Christen,et al.  The Extract of Ginkgo biloba EGb 761 Reactivates a Juvenile Profile in the Skeletal Muscle of Sarcopenic Rats by Transcriptional Reprogramming , 2009, PloS one.

[25]  J. E. Morley.  Vitamin d redux. , 2009, Journal of the American Medical Directors Association.

[26]  Todd A. Lee,et al.  Vitamin d deficiency/insufficiency practice patterns in a veterans health administration long-term care population: a retrospective analysis. , 2009, Journal of the American Medical Directors Association.

[27]  C. Dieli-Conwright,et al.  Influence of hormone replacement therapy on eccentric exercise induced myogenic gene expression in postmenopausal women. , 2009, Journal of applied physiology.

[28]  J. Manson,et al.  Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial , 2009, The Lancet.

[29]  G. Onder,et al.  Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia , 2009, The journal of nutrition, health & aging.

[30]  A. Kenny,et al.  Self‐Reported Dietary Intake of Omega‐3 Fatty Acids and Association with Bone and Lower Extremity Function , 2009, Journal of the American Geriatrics Society.

[31]  R. S. Sohal,et al.  Prolonged intake of coenzyme Q10 impairs cognitive functions in mice. , 2009, The Journal of nutrition.

[32]  I. Dionne,et al.  Changes in muscle mass and strength after menopause. , 2009, Journal of musculoskeletal & neuronal interactions.

[33]  J B Wong,et al.  Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials , 2009, BMJ : British Medical Journal.

[34]  J. Morley,et al.  Developing novel therapeutic approaches to frailty. , 2009, Current pharmaceutical design.

[35]  G. Frühbeck,et al.  Leptin Administration Favors Muscle Mass Accretion by Decreasing FoxO3a and Increasing PGC-1α in ob/ob Mice , 2009, PloS one.

[36]  L. Blizzard,et al.  Statin therapy, muscle function and falls risk in community-dwelling older adults. , 2009, QJM : monthly journal of the Association of Physicians.

[37]  C. Dieli-Conwright,et al.  Hormone therapy attenuates exercise-induced skeletal muscle damage in postmenopausal women. , 2009, Journal of applied physiology.

[38]  M. Lazaretti-Castro,et al.  Treatment of Vitamin D Deficiency Increases Lower Limb Muscle Strength in Institutionalized Older People Independently of Regular Physical Activity: A Randomized Double-Blind Controlled Trial , 2009, Annals of Nutrition and Metabolism.

[39]  A. Vaag,et al.  Skeletal muscle structural lipids improve during weight-maintenance after a very low calorie dietary intervention , 2009, Lipids in Health and Disease.

[40]  M. Jois,et al.  Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet , 2009, Physiology & Behavior.

[41]  M. Delp,et al.  Effects of ageing and exercise training on eNOS uncoupling in skeletal muscle resistance arterioles , 2009, The Journal of physiology.

[42]  B. Miller,et al.  The interactions of some commonly consumed drugs with mitochondrial adaptations to exercise. , 2009, Journal of applied physiology.

[43]  K. Tsuchida,et al.  Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. , 2009, American journal of physiology. Endocrinology and metabolism.

[44]  X. Bigard,et al.  HIGHLIGHTED TOPIC Regulation of Protein Metabolism in Exercise and Recovery Decreased muscle ACE activity enhances functional response to endurance training in rats, without change in muscle oxidative capacity or contractile phenotype , 2009 .

[45]  D. Bunout,et al.  Effects of enalapril or nifedipine on muscle strength or functional capacity in elderly subjects. A double blind trial , 2009, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[46]  K. Sunagawa,et al.  Inhibition of Tumor Necrosis Factor-α–Induced Interleukin-6 Expression by Telmisartan Through Cross-Talk of Peroxisome Proliferator-Activated Receptor-γ With Nuclear Factor &kgr;B and CCAAT/Enhancer-Binding Protein-β , 2009, Hypertension.

[47]  A. Hoffman,et al.  Effects of an oral growth hormone secretagogue in older adults. , 2009, The Journal of clinical endocrinology and metabolism.

[48]  J. Fulford,et al.  Influence of dietary creatine supplementation on muscle phosphocreatine kinetics during knee-extensor exercise in humans. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[49]  A. Vigano,et al.  Relationship Between Angiotensin-Converting Enzyme Gene Polymorphism and Body Composition, Functional Performance, and Blood Biomarkers in Advanced Cancer Patients , 2009, Clinical Cancer Research.

[50]  R. Collins,et al.  Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people , 2009, BMC clinical pharmacology.

[51]  J. Mendell,et al.  Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease , 2009, Muscle & nerve.

[52]  M. Horowitz,et al.  Effect of testosterone and a nutritional supplement, alone and in combination, on hospital admissions in undernourished older men and women. , 2009, The American journal of clinical nutrition.

[53]  S. Wild,et al.  Muscle Microvascular Dysfunction in Central Obesity Is Related to Muscle Insulin Insensitivity but Is Not Reversed by High-Dose Statin Treatment , 2009, Diabetes.

[54]  J. Wishart,et al.  Fasting ghrelin is related to skeletal muscle mass in healthy adults , 2009, European journal of nutrition.

[55]  J. Kaufman,et al.  Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. , 2009, European urology.

[56]  D. Freyssenet,et al.  Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle. , 2009, Endocrinology.

[57]  H. Minne,et al.  Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals , 2009, Osteoporosis International.

[58]  M. Holick.  The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. , 2008, Molecular aspects of medicine.

[59]  F. Booth,et al.  Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia. , 2008, Journal of applied physiology.

[60]  F. Harrell,et al.  Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults , 2008, Annals of Internal Medicine.

[61]  S. Giovannini,et al.  Modulation of GH/IGF-1 axis: Potential strategies to counteract sarcopenia in older adults , 2008, Mechanisms of Ageing and Development.

[62]  S. Cornish,et al.  Low-dose creatine combined with protein during resistance training in older men. , 2008, Medicine and science in sports and exercise.

[63]  T. Meade,et al.  Health related quality of life after combined hormone replacement therapy: randomised controlled trial , 2008, BMJ : British Medical Journal.

[64]  E. Porteri,et al.  Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats , 2008, Journal of hypertension.

[65]  M. Mcmurdo,et al.  ACE inhibitors as a therapy for sarcopenia — Evidence and possible mechanisms , 2008, The journal of nutrition, health & aging.

[66]  J. E. Morley,et al.  Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives , 2008, The journal of nutrition, health & aging.

[67]  K. Tsuchida.  Targeting myostatin for therapies against muscle-wasting disorders. , 2008, Current opinion in drug discovery & development.

[68]  W. Kraus,et al.  Impact of hormone replacement therapy on exercise training-induced improvements in insulin action in sedentary overweight adults. , 2008, Metabolism: clinical and experimental.

[69]  R. Prince,et al.  Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer , 2008, BJU international.

[70]  Nathan R. Qi,et al.  Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-γ dependent pathway , 2008, Journal of hypertension.

[71]  A. LaCroix,et al.  Statin use and incident frailty in women aged 65 years or older: prospective findings from the Women's Health Initiative Observational Study. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[72]  J. Mendell,et al.  Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors , 2008, Proceedings of the National Academy of Sciences.

[73]  Y. Rolland,et al.  Frailty: toward a clinical definition. , 2008, Journal of the American Medical Directors Association.

[74]  K. Tsuchida,et al.  Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  Konstantin I Bakhurin,et al.  Tendons of myostatin-deficient mice are small, brittle, and hypocellular , 2008, Proceedings of the National Academy of Sciences.

[76]  D. Grobbee,et al.  Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. , 2008, JAMA.

[77]  C. Cooper,et al.  Diet and Its Relationship with Grip Strength in Community‐Dwelling Older Men and Women: The Hertfordshire Cohort Study , 2008, Journal of the American Geriatrics Society.

[78]  V. Kashyap.  Statin Use and Functional Decline in Patients With and Without Peripheral Arterial Disease , 2008 .

[79]  E. Barrett,et al.  Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition. , 2007, American journal of physiology. Endocrinology and metabolism.

[80]  Y. Christen,et al.  Ginkgo biloba extract EGb 761 and Wisconsin Ginseng delay sarcopenia in Caenorhabditis elegans. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[81]  Jeffrey R Stout,et al.  Effects of creatine supplementation on the onset of neuromuscular fatigue threshold and muscle strength in elderly men and women (64 - 86 years). , 2007, The journal of nutrition, health & aging.

[82]  M. Mcmurdo,et al.  Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial , 2007, Canadian Medical Association Journal.

[83]  M. Tarnopolsky,et al.  Creatine Monohydrate and Conjugated Linoleic Acid Improve Strength and Body Composition Following Resistance Exercise in Older Adults , 2007, PloS one.

[84]  S. Sheather,et al.  Statins and dietary and serum cholesterol are associated with increased lean mass following resistance training. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[85]  S. Kežić,et al.  Postmenopausal HRT and tibolone in relation to muscle strength and body composition. , 2007, Maturitas.

[86]  R. Kambadur,et al.  Antagonism of myostatin enhances muscle regeneration during sarcopenia. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[87]  Haixia Wang,et al.  Discovery of potent and muscle selective androgen receptor modulators through scaffold modifications. , 2007, Journal of medicinal chemistry.

[88]  Jose M Garcia,et al.  Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers. , 2007, The oncologist.

[89]  Hirokazu Takahashi,et al.  Telmisartan, An Angiotensin II Type 1 Receptor Blocker, Controls Progress of Nonalcoholic Steatohepatitis in Rats , 2007, Digestive Diseases and Sciences.

[90]  Wenqing Gao,et al.  Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs). , 2007, Drug discovery today.

[91]  J. Concato,et al.  Effects of Statin Use on Muscle Strength, Cognition, and Depressive Symptoms in Older Adults , 2007, Journal of the American Geriatrics Society.

[92]  M. Cesari,et al.  Use of ACE inhibitors is associated with elevated levels of IGFBP-3 among hypertensive older adults: results from the IlSIRENTE study , 2007, European Journal of Clinical Pharmacology.

[93]  J. Weber,et al.  Relationship between n-3 PUFA content and energy metabolism in the flight muscles of a migrating shorebird: evidence for natural doping , 2007, Journal of Experimental Biology.

[94]  C. Ruxton,et al.  The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. , 2007, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[95]  Adeeba Kamarulzaman,et al.  AIDS Res Hum Retroviruses , 2006 .

[96]  G. Ostir,et al.  Androgen Treatment and Muscle Strength in Elderly Men: A Meta‐Analysis , 2006, Journal of the American Geriatrics Society.

[97]  P. Bouloux,et al.  Modifying muscle mass - the endocrine perspective. , 2006, The Journal of endocrinology.

[98]  K. Tsuchida,et al.  Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition. , 2006, The Journal of clinical investigation.

[99]  S. Fortuni,et al.  Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors , 2006, Nature Medicine.

[100]  M. Guida,et al.  Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene , 2006, Menopause.

[101]  D. Langin.  Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. , 2006, Pharmacological research.

[102]  G. W. Payne.  Effect of Inflammation on the Aging Microcirculation: Impact on Skeletal Muscle Blood Flow Control , 2006, Microcirculation.

[103]  P. Aagaard,et al.  Creatine supplementation augments the increase in satellite cell and myonuclei number in human skeletal muscle induced by strength training , 2006, The Journal of physiology.

[104]  V. Montori,et al.  Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. , 2006, The Journal of clinical endocrinology and metabolism.

[105]  P. Calder,et al.  n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. , 2006, The American journal of clinical nutrition.

[106]  M. Pahor,et al.  Effects of ACE inhibitors on skeletal muscle. , 2006, Current pharmaceutical design.

[107]  S. Bandinelli,et al.  Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age (the InCHIANTI study). , 2006, The American journal of cardiology.

[108]  R. Wolfe,et al.  Insulin resistance of muscle protein metabolism in aging , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[109]  P. Sestili,et al.  Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity. , 2006, Free radical biology & medicine.

[110]  H. Bischoff-Ferrari,et al.  Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. , 2006, Archives of internal medicine.

[111]  H. Katus,et al.  Angiotensin II Stimulates Matrix Metalloproteinase Secretion in Human Vascular Smooth Muscle Cells via Nuclear Factor-κB and Activator Protein 1 in a Redox-Sensitive Manner , 2005, Journal of Vascular Research.

[112]  M. Boyanov,et al.  Effects of tibolone on body composition in postmenopausal women: a 1-year follow up study. , 2005, Maturitas.

[113]  M. Esbjörnsson,et al.  Oestrogen receptor β is present in both muscle fibres and endothelial cells within human skeletal muscle tissue , 2005, Histochemistry and Cell Biology.

[114]  S. Rubin,et al.  Angiotensin-converting enzyme insertion/deletion genotype, exercise, and physical decline. , 2005, JAMA.

[115]  S. Bhasin,et al.  Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells. , 2005, Endocrinology.

[116]  E. Wouters,et al.  Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease , 2005, Thorax.

[117]  Matthew T. Haren,et al.  Frailty and the aging male , 2005, The aging male : the official journal of the International Society for the Study of the Aging Male.

[118]  D. Vassilopoulos,et al.  Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection , 2004, Annals of the rheumatic diseases.

[119]  J. Williamson,et al.  Antihypertensive Medications and Differences in Muscle Mass in Older Persons: The Health, Aging and Body Composition Study , 2004, Journal of the American Geriatrics Society.

[120]  A. Sahu,et al.  Minireview: A hypothalamic role in energy balance with special emphasis on leptin. , 2004, Endocrinology.

[121]  S. M. Robinson,et al.  Triglycerides induce leptin resistance at the blood-brain barrier. , 2004, Diabetes.

[122]  Mar Alvarez,et al.  The Rapid Effects of 1,25-Dihydroxyvitamin D3 Require the Vitamin D Receptor and Influence 24-Hydroxylase Activity , 2004, Journal of Biological Chemistry.

[123]  G. Onder,et al.  Pharmacoepidemiology and disability in older adults: can medications slow the age-related decline in physical function? , 2004, Expert opinion on pharmacotherapy.

[124]  Marc S. Williams.  Myostatin mutation associated with gross muscle hypertrophy in a child. , 2004, The New England journal of medicine.

[125]  J. Cauley,et al.  Vitamin D receptor genotype is associated with fat-free mass and sarcopenia in elderly men. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[126]  F. Gudat,et al.  In Situ Detection of 1,25-dihydroxyvitamin D Receptor In human Skeletal Muscle Tissue , 2004, The Histochemical Journal.

[127]  Marjolein Visser,et al.  Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. , 2003, The Journal of clinical endocrinology and metabolism.

[128]  M. Tarnopolsky,et al.  Effect of creatine and weight training on muscle creatine and performance in vegetarians. , 2003, Medicine and science in sports and exercise.

[129]  S. Wassall,et al.  Docosahexaenoic acid: membrane properties of a unique fatty acid. , 2003, Chemistry and physics of lipids.

[130]  R. Porcher,et al.  Changes in body composition during post-menopausal hormone therapy: a 2 year prospective study. , 2003, Human reproduction.

[131]  Matthew T. Haren,et al.  Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[132]  Alun Jones,et al.  Skeletal muscle RAS and exercise performance. , 2003, The international journal of biochemistry & cell biology.

[133]  J. Rosene,et al.  Effects of oral creatine and resistance training on myogenic regulatory factor expression. , 2003, Medicine and science in sports and exercise.

[134]  Tim Cheetham,et al.  Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. , 2003, The New England journal of medicine.

[135]  P. Delamarche,et al.  Estrogen receptor alpha mRNA in human skeletal muscles. , 2003, Medicine and science in sports and exercise.

[136]  R. Lew,et al.  Effects of Vitamin D and Calcium Supplementation on Falls: A Randomized Controlled Trial , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[137]  S. Miura,et al.  The I allele of the angiotensin‐converting enzyme gene is associated with an increased percentage of slow‐twitch type I fibers in human skeletal muscle , 2003, Clinical genetics.

[138]  J. Vaupel,et al.  Angiotensin I-converting enzyme (ACE) gene polymorphism in relation to physical performance, cognition and survival--a follow-up study of elderly Danish twins. , 2003, Annals of epidemiology.

[139]  Gianni Parise,et al.  Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[140]  J. Patrie,et al.  Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men. , 2002, The Journal of clinical endocrinology and metabolism.

[141]  J. Sorkin,et al.  Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. , 2002 .

[142]  M. Samson,et al.  Vitamin D deficiency, muscle function, and falls in elderly people. , 2002, The American journal of clinical nutrition.

[143]  J. Williamson,et al.  Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study , 2002, The Lancet.

[144]  S. Humphries,et al.  Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release , 2002, Heart.

[145]  J. Bülow,et al.  GH administration changes myosin heavy chain isoforms in skeletal muscle but does not augment muscle strength or hypertrophy, either alone or combined with resistance exercise training in healthy elderly men. , 2002, The Journal of clinical endocrinology and metabolism.

[146]  M. Samson,et al.  Muscle strength and tibolone: a randomised, double‐blind, placebo‐controlled trial , 2002, BJOG : an international journal of obstetrics and gynaecology.

[147]  K. Chad,et al.  Creatine supplementation combined with resistance training in older men. , 2001, Medicine and science in sports and exercise.

[148]  M. Samson,et al.  The effect of tibolone on fat mass, fat-free mass, and total body water in postmenopausal women. , 2001, Endocrinology.

[149]  S. Takeshita,et al.  Angiotensin-converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats. , 2001, Cardiovascular research.

[150]  WataruShimizu,et al.  Chronic Administration of Ghrelin Improves Left Ventricular Dysfunction and Attenuates Development of Cardiac Cachexia in Rats With Heart Failure , 2001 .

[151]  David Handelsman,et al.  A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. , 2001, The Journal of clinical endocrinology and metabolism.

[152]  K. Yarasheski,et al.  Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis. , 2001, Journal of applied physiology.

[153]  D. Kiel,et al.  Growth Hormone Administration and Exercise Effects on Muscle Fiber Type and Diameter in Moderately Frail Older People , 2001, Journal of the American Geriatrics Society.

[154]  A. Kenny,et al.  Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[155]  J. Chrast,et al.  Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. , 2001, Endocrinology.

[156]  R. Curi,et al.  The response of skeletal muscle to leptin. , 2001, Frontiers in bioscience : a journal and virtual library.

[157]  H. Perry,et al.  Testosterone and leptin in older African-American men: relationship to age, strength, function, and season. , 2000, Metabolism: clinical and experimental.

[158]  H. Minne,et al.  Effects of a Short‐Term Vitamin D and Calcium Supplementation on Body Sway and Secondary Hyperparathyroidism in Elderly Women , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[159]  H. E. Montgomery,et al.  Physiology: The ACE gene and muscle performance , 2000, Nature.

[160]  P. Clarkson,et al.  Acute Creatine Supplementation in Older Men , 2000, International journal of sports medicine.

[161]  K. Chihara,et al.  Effect of recombinant human growth hormone in elderly osteoporotic women , 1999, Clinical endocrinology.

[162]  K. Fearon,et al.  The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer , 1999, British Journal of Cancer.

[163]  A. Musarò,et al.  IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1 , 1999, Nature.

[164]  P. Libby,et al.  Angiotensin induces inflammatory activation of human vascular smooth muscle cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[165]  M. Francaux,et al.  Effects of training and creatine supplement on muscle strength and body mass , 1999, European Journal of Applied Physiology and Occupational Physiology.

[166]  P. Clarkson,et al.  Effects of 30 days of creatine ingestion in older men , 1999, European Journal of Applied Physiology and Occupational Physiology.

[167]  R. Baumgartner,et al.  Predictors of skeletal muscle mass in elderly men and women , 1999, Mechanisms of Ageing and Development.

[168]  Jimmy D Bell,et al.  Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training , 1999, The Lancet.

[169]  M. Runge,et al.  B Transcription Factors κ Through Pleiotropic Activation of Nuclear Factor-Angiotensin II Induces Interleukin-6 Transcription in Vascular Smooth Muscle Cells , 1999 .

[170]  S. Bermon,et al.  Effects of creatine monohydrate ingestion in sedentary and weight-trained older adults. , 1998, Acta physiologica Scandinavica.

[171]  F. Horber,et al.  Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women , 1998, Clinical endocrinology.

[172]  Jimmy D Bell,et al.  Human gene for physical performance , 1998, Nature.

[173]  J. Yesavage,et al.  Effects of human growth hormone, insulin-like growth factor I, and diet and exercise on body composition of obese postmenopausal women. , 1998, The Journal of clinical endocrinology and metabolism.

[174]  P. Haslett,et al.  The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus. , 1997, AIDS research and human retroviruses.

[175]  R N Pierson,et al.  Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. , 1997, Journal of applied physiology.

[176]  H. Perry,et al.  Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. , 1997, The Journal of clinical endocrinology and metabolism.

[177]  P J Garry,et al.  Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. , 1997, Metabolism: clinical and experimental.

[178]  D. Schoenfeld,et al.  Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. , 1996, The Journal of clinical endocrinology and metabolism.

[179]  S. Welle,et al.  Growth hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60 years old. , 1996, The Journal of clinical endocrinology and metabolism.

[180]  H. Schunkert,et al.  Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. , 1995, Circulation.

[181]  B. Sjödin,et al.  Skeletal muscle metabolism during short duration high-intensity exercise: influence of creatine supplementation. , 1995, Acta physiologica Scandinavica.

[182]  J. Floras,et al.  Insulin-mediated increase in blood flow is impaired in the elderly. , 1995, The Journal of clinical endocrinology and metabolism.

[183]  K. Yarasheski,et al.  Effect of growth hormone and resistance exercise on muscle growth and strength in older men. , 1995, The American journal of physiology.

[184]  P. Vollenweider,et al.  Nitric oxide release accounts for insulin's vascular effects in humans. , 1994, The Journal of clinical investigation.

[185]  R L Hintz,et al.  Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. , 1994, The Journal of clinical endocrinology and metabolism.

[186]  N. Fineberg,et al.  Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. , 1994, The Journal of clinical investigation.

[187]  H. Perry,et al.  Effects of Testosterone Replacement Therapy in Old Hypogonadal Males: A Preliminary Study , 1993, Journal of the American Geriatrics Society.

[188]  J. S. Tenover,et al.  Effects of testosterone supplementation in the aging male. , 1992, The Journal of clinical endocrinology and metabolism.

[189]  T. Orfeo,et al.  Cardiac and skeletal muscle adaptations to training in systemic hypertension and effect of beta blockade (metoprolol or propranolol). , 1990, The American journal of cardiology.

[190]  R. Boland.  Role of vitamin D in skeletal muscle function. , 1986, Endocrine reviews.

[191]  M. Norman,et al.  Vitamin D Deficiency, hypocalcemia, and increased skeletal muscle degradation in rats. , 1983, The Journal of clinical investigation.

[192]  M. Kutner,et al.  Impaired growth hormone secretion in the adult population: relation to age and adiposity. , 1981, The Journal of clinical investigation.

[193]  G. Leveille,et al.  Skeletal muscle accretion and turnover in lean and obese (ob/ob) mice. , 1979, Metabolism: clinical and experimental.

[194]  B. Saltin,et al.  Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. , 1979, Clinical science.